74 related articles for article (PubMed ID: 16495741)
1. Atorvastatin improves myocardial perfusion in a patient with hypercholesterolemia and single-vessel coronary disease.
Feola M; Biggi A; Rolfo F; Papaleo A; Chauvie S; La Scala E; Uslenghi E
Clin Nucl Med; 2006 Mar; 31(3):166-7. PubMed ID: 16495741
[No Abstract] [Full Text] [Related]
2. [Results of randomized study: intensive lipid lowering treatment stops coronary atherosclerosis].
MMW Fortschr Med; 2004 Mar; 146(13):64-5. PubMed ID: 15219142
[No Abstract] [Full Text] [Related]
3. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial.
Raggi P; Callister TQ; Davidson M; Welty FK; Bachmann GA; Laskey R; Pittman D; Kafonek S; Scott R
Am Heart J; 2001 May; 141(5):722-6. PubMed ID: 11320358
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither.
Conard S; Bays H; Leiter LA; Bird S; Lin J; Hanson ME; Shah A; Tershakovec AM
Diabetes Obes Metab; 2010 Mar; 12(3):210-8. PubMed ID: 20151997
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
[TBL] [Abstract][Full Text] [Related]
6. Tendinous xanthoma.
Kumar KV; Ghosh AK; Kumar KK; Prusty P
J Assoc Physicians India; 2012 Mar; 60():46. PubMed ID: 22799114
[No Abstract] [Full Text] [Related]
7. Atorvastatin treatment improves myocardial and peripheral blood flow in familial hypercholesterolemia subjects without evidence of coronary atherosclerosis.
Lario FC; Miname MH; Tsutsui JM; Santos RD; Kowatsch I; Sbano JC; Ramires JA; Kalil Filho R; Mathias W
Echocardiography; 2013 Jan; 30(1):64-71. PubMed ID: 22957727
[TBL] [Abstract][Full Text] [Related]
8. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel A; Sawicki PT
MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
[No Abstract] [Full Text] [Related]
9. [Atorvastatin for secondary prevention in patients with coronary artery disease].
Zateĭshchikova AA; Sidorenko BA
Kardiologiia; 2011; 51(12):63-9. PubMed ID: 22304319
[No Abstract] [Full Text] [Related]
10. [Regression of a large lipid-rich pool in the coronary artery during treatment with statin detected by intravascular ultrasound: a case report].
Takashima H; Yasukawa T; Ozaki Y; Asai K; Shinjo H; Waseda K; Kuroda Y; Wakita Y; Kosaka T; Kuhara Y; Ito T
J Cardiol; 2006 Jun; 47(6):307-12. PubMed ID: 16800374
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
[TBL] [Abstract][Full Text] [Related]
12. Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography.
Hinoi T; Matsuo S; Tadehara F; Tsujiyama S; Yamakido M
Am J Cardiol; 2005 Jul; 96(1):89-91. PubMed ID: 15979441
[TBL] [Abstract][Full Text] [Related]
13. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.
Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I
Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932
[TBL] [Abstract][Full Text] [Related]
14. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
[TBL] [Abstract][Full Text] [Related]
15. Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin.
Dobreanu M; Dobreanu D; Fodor A; Bacarea A
Rom J Intern Med; 2007; 45(2):193-9. PubMed ID: 18333374
[TBL] [Abstract][Full Text] [Related]
16. Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging.
Komiyama N
Circ J; 2009 Apr; 73(4):628-9. PubMed ID: 19318726
[No Abstract] [Full Text] [Related]
17. [Influence of prolonged statin therapy on the arterial distensibility in stable ischemic heart disease].
Kurpesa M; Tymiński M; Trzos E; Kidawa M; Krzemińska-Pakuła M
Przegl Lek; 2005; 62(4):210-3. PubMed ID: 16229236
[TBL] [Abstract][Full Text] [Related]
18. High-intensity statin treatment for coronary heart disease.
Sacks FM
JAMA; 2004 Mar; 291(9):1132-4. PubMed ID: 14996784
[No Abstract] [Full Text] [Related]
19. Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve.
Makkena B; Salti H; Subramaniam M; Thennapan S; Bonow RH; Caira F; Bonow RO; Spelsberg TC; Rajamannan NM
J Am Coll Cardiol; 2005 Feb; 45(4):631-3. PubMed ID: 15708716
[No Abstract] [Full Text] [Related]
20. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin.
Nakad A; Bataille L; Hamoir V; Sempoux C; Horsmans Y
Lancet; 1999 May; 353(9166):1763-4. PubMed ID: 10347994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
